LS Marine Solution Co., Ltd. (KOSDAQ:060370)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2012	FY 2011	FY 2010
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Market Capitalization	809,699	463,267	268,794	54,263	54,263	84,477
Market Cap Growth	608.00%	72.35%	395.36%	-	-35.77%	35.20%
Enterprise Value	712,333	452,101	257,629	60,697	64,729	69,192
Last Close Price	25850.00	12815.98	9367.80	1986.42	1909.72	2863.38
PE Ratio	41.78	35.09	23.14	6.82	8.10	21.66
PS Ratio	5.03	3.56	3.80	0.79	0.49	1.20
PB Ratio	3.93	2.23	2.19	0.64	0.69	1.22
P/TBV Ratio	4.03	2.28	2.20	0.65	0.70	1.23
P/OCF Ratio	162.73	-	15.77	11.12	3.94	27.69
EV/Sales Ratio	4.42	3.47	3.64	0.88	0.58	0.98
EV/EBITDA Ratio	25.99	21.28	13.18	-	3.76	6.51
EV/EBIT Ratio	39.03	36.48	19.69	6.12	6.21	18.05
EV/FCF Ratio	-220.95	-	-	-	-	-
Debt / Equity Ratio	0.02	0.01	0.00	0.15	0.30	0.26
Debt / EBITDA Ratio	0.13	0.08	0.02	-	1.37	1.71
Asset Turnover	-	0.65	-	0.58	0.99	0.70
Inventory Turnover	-	65.15	-	78.89	86.80	64.99
Quick Ratio	2.69	3.51	2.50	0.86	1.33	2.59
Current Ratio	2.83	3.74	2.80	1.77	1.61	2.79
Return on Equity (ROE)	10.81%	7.98%	-	9.71%	9.05%	5.78%
Return on Assets (ROA)	-	3.86%	-	5.23%	5.76%	2.39%
Return on Capital (ROIC)	6.86%	4.66%	-	6.19%	6.86%	2.67%
Return on Capital Employed (ROCE)	8.80%	5.90%	10.70%	11.00%	11.40%	4.70%
Earnings Yield	2.19%	2.85%	4.32%	14.65%	12.35%	4.62%
FCF Yield	-0.40%	-3.29%	-13.61%	-10.89%	-25.41%	-4.56%
Dividend Yield	0.64%	1.25%	-	-	-	1.75%
Payout Ratio	22.17%	29.80%	6.35%	25.85%	4.37%	33.86%
Buyback Yield / Dilution	-39.36%	-9.82%	-19.62%	-0.03%	0.01%	-
Total Shareholder Return	-38.72%	-8.57%	-19.62%	-0.03%	0.01%	1.75%

Updated Nov 14, 2013. Source: S&P Global Market Intelligence. Standard template. Financial Sources.